Technology

Ora Chief Medical Officer Gustavo De Moraes, MD, PhD, MPH, speak with Ophthalmology Times®' Sheryl Stevenson to discuss some of the cutting-edge advancements in therapies and diagnostics for the treatment of glaucoma patients.

Glaucoma 360's co-founders and co-chairs Adrienne L. Graves, PhD, and Andrew G. Iwach, MD, speak with Ophthalmology Times®' Sheryl Stevenson on what attendees can expect from this year's annual meeting.

The Toronto-based medical eyewear company partnered with the visual assistance community to help empower an Oregon college student with enhanced vision.

Moore suffered from dry eye disease and Lumenis noted that treatment with OptiLight improved her condition. Now she’s partnering with the company to share her story and empower others.

The company noted that the study was the first to evaluate whether AI software can accurately detect more-than-mild diabetic retinopathy using a single image per eye, obtained from either a desktop or handheld retinal camera.

The rate of adverse events was low in this higher risk, difficult-to-manage population of special-needs children, noted Margaret Reynolds, MD.

TearLab Corp. announced that Adam Szaronos has been appointed president and CEO by the company's Board of Directors, effective immediately.

Using its proprietary software, the company has been able to create models in a fraction of the time typically needed for fitting one.

The company’s re:Vive technology features 6 vision diagnostic exams, supported by 5 reimbursable CPT codes in 1 wearable solution.

Lens combines diffractive multifocal and extended depth-of-focus properties.

“Real talk” on new devices gives surgeons, patients decision-making insights

Diagnostics, imaging, and therapeutics pave the way for better outcomes.

Pilot study tests the technology to obtain remote fundus imaging of patients.

Patients can get real-time disease monitoring with self-operated device.

Changes are resulting in better outcomes for patients with glaucoma.

Investigators learn that a wearable aid can offer improved mobility.

Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.

Technology can track the progression of retinal abnormalities

Lens an option for complicated eyes, astigmatism, monovision candidates.

Pilot study shows promise of teaching surgeons with technology.

Anat Loewenstein, MD, MHA, discusses how artificial intelligence can optimize optical coherence tomography.

Cotargeted therapy could help combat inherited retinal diseases.

Taking control of a practice’s future with investment, creative thinking

Heru Inc., announced Thursday that it has partnered with Vision Source on the commercial availability launch of re:Vive, a wearable diagnostics and visual field application.